Advertisement

Advertisement

GB:OXB Stock Latest News

Oxford Biomedica unveils fast-track viral vector service to speed gene therapy development

Company AnnouncementsOxford Biomedica unveils fast-track viral vector service to speed gene therapy development

Oxford Biomedica Reinstates and Grants New Performance‑Linked Share Awards to Leadership

PremiumCompany Announcements

Oxford Biomedica Reinstates and Grants New Performance‑Linked Share Awards to Leadership

5d ago

Oxford Biomedica Confirms Updated Total Voting Rights

PremiumCompany Announcements

Oxford Biomedica Confirms Updated Total Voting Rights

12d ago

Oxford Biomedica sets date for 2026 AGM as it underscores cell and gene therapy CDMO role

PremiumCompany Announcements

Oxford Biomedica sets date for 2026 AGM as it underscores cell and gene therapy CDMO role

14d ago

Oxford BioMedica Returns to Profit as U.S. Expansion and Big Pharma Deals Lift Outlook

PremiumCompany Announcements

Oxford BioMedica Returns to Profit as U.S. Expansion and Big Pharma Deals Lift Outlook

18d ago

Oxford Biomedica resumed with a Buy at Jefferies

PremiumThe FlyOxford Biomedica resumed with a Buy at Jefferies

21d ago

OXB enters licensing agreement with Viral Vector Manufacturing Facility

The Fly

OXB enters licensing agreement with Viral Vector Manufacturing Facility

26d ago

Oxford Biomedica licenses viral vector platforms to Australian CDMO VVMF

Company Announcements

Oxford Biomedica licenses viral vector platforms to Australian CDMO VVMF

26d ago

Oxford Biomedica Adds Incentive Scheme Shares to London Listing

PremiumCompany Announcements

Oxford Biomedica Adds Incentive Scheme Shares to London Listing

1M ago

Oxford Biomedica Seeks LSE Admission for 92,381 New Incentive Shares

PremiumCompany Announcements

Oxford Biomedica Seeks LSE Admission for 92,381 New Incentive Shares

1M ago

Oxford Biomedica sets Capital Markets Day and tightens investor outreach calendar

PremiumCompany Announcements

Oxford Biomedica sets Capital Markets Day and tightens investor outreach calendar

1M ago

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

PremiumCompany Announcements

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

1M ago

Oxford Biomedica rejects EQT approaches as suitor walks away

PremiumCompany AnnouncementsOxford Biomedica rejects EQT approaches as suitor walks away

2M ago

Oxford Biomedica sees FY25 revenue GBP 166M -GBP 169M

The Fly

Oxford Biomedica sees FY25 revenue GBP 166M -GBP 169M

2M ago

Oxford Biomedica sees FY26 revenue GBP 220M -GBP 240M

The Fly

Oxford Biomedica sees FY26 revenue GBP 220M -GBP 240M

2M ago

Oxford Biomedica hits top-end 2025 guidance and turns EBITDA positive

PremiumCompany Announcements

Oxford Biomedica hits top-end 2025 guidance and turns EBITDA positive

2M ago

Oxford Biomedica Wins More Time for EQT Takeover Decision

PremiumCompany Announcements

Oxford Biomedica Wins More Time for EQT Takeover Decision

2M ago

Oxford Biomedica seals multi-year CAR-T vector supply deal with Bristol Myers Squibb

PremiumCompany Announcements

Oxford Biomedica seals multi-year CAR-T vector supply deal with Bristol Myers Squibb

2M ago

Oxford Biomedica Confirms Total Voting Rights at 120.8 Million Shares

PremiumCompany Announcements

Oxford Biomedica Confirms Total Voting Rights at 120.8 Million Shares

2M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe FlyBiotech Alert: Searches spiking for these stocks today

3M ago

Oxford Biomedica Confirms Preliminary Takeover Talks After Unsolicited EQT Approach

Company Announcements

Oxford Biomedica Confirms Preliminary Takeover Talks After Unsolicited EQT Approach

3M ago

Oxford Biomedica upgraded to Buy from Hold at Deutsche Bank

The Fly

Oxford Biomedica upgraded to Buy from Hold at Deutsche Bank

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >